表紙
市場調查報告書

髖關節重組:開發平台分析

Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 341587
出版日期 內容資訊 英文 212 Pages
訂單完成後即時交付
價格
髖關節重組:開發平台分析 Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年10月11日內容資訊: 英文 212 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的髖關節重組之開發中產品資訊分析,提供您臨床實驗與產品開發的進展,各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 髖關節重組概要

第3章 開發中的產品

  • 髖關節重組 - 各開發階段的開發中產品
  • 髖關節重組 - 各市場區隔的開發中產品
  • 髖關節重組 -國家 (地區) 別的開發中產品
  • 髖關節重組 - 法規別的開發中產品
  • 髖關節重組 - 核准時期 (估計) 別的開發中產品
  • 髖關節重組 - 現在進行中的臨床實驗

第4章 髖關節重組 - 正在開發的開發中產品:各企業

  • 髖關節重組企業 - 各開發階段的開發中產品
  • 髖關節重組 - 各開發階段的開發中產品

第5章 髖關節重組企業與產品概要

  • Amedica Corporation
  • Bonovo Orthopedics, Inc.
  • Corentec Co., Ltd.
  • Corin Group Plc
  • DePuy Companies
  • Dimicron Inc.
  • Exactech, Inc.
  • Fortis Orthopedics
  • Fraunhofer Institute for Applied Polymer Research
  • Implants International Limited
  • INOR Orthopaedics
  • JRI Orthopaedics Ltd
  • 京瓷醫學
  • Limacorporate S.p.a.
  • MX Orthopedics, Corp.
  • Nano Interface Technology, Inc.
  • Naviswiss AG
  • OrthoGrid Systems
  • OrthoPediatrics Corp.
  • PLD Corporation Limited (Inactive)
  • PreSRV Ltd.
  • Renova Orthopedics, LLC
  • SAS HyPrevention
  • SINTEF
  • Stryker Corporation
  • Tech Manage Corp.
  • University of Alberta
  • University of South Florida
  • University of Warwick
  • Zimmer Biomet Holdings, Inc.

第6章 髖關節重組 - 最近的趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0799EPD

GlobalData's Medical Devices sector report, "Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Hip Reconstruction Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hip Reconstruction Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hip Reconstruction Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hip Reconstruction Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hip Reconstruction Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.2 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Hip Reconstruction Devices Overview

3 Products under Development

  • 3.1 Hip Reconstruction Devices - Pipeline Products by Stage of Development
  • 3.2 Hip Reconstruction Devices - Pipeline Products by Segment
  • 3.3 Hip Reconstruction Devices - Pipeline Products by Territory
  • 3.4 Hip Reconstruction Devices - Pipeline Products by Regulatory Path
  • 3.5 Hip Reconstruction Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Hip Reconstruction Devices - Ongoing Clinical Trials

4 Hip Reconstruction Devices - Pipeline Products under Development by Companies

  • 4.1 Hip Reconstruction Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Hip Reconstruction Devices - Pipeline Products by Stage of Development

5 Hip Reconstruction Devices Companies and Product Overview

  • 5.1 4iBIO Company Overview
  • 5.2 4-Web Spine, LLC Company Overview
  • 5.3 BioPoly RS LLC Company Overview
  • 5.4 Biotechni SAS Company Overview
  • 5.5 Bonovo Orthopedics Inc Company Overview
  • 5.6 CeramTec GmbH Company Overview
  • 5.7 ConforMIS Inc Company Overview
  • 5.8 Corin Group Plc Company Overview
  • 5.9 DePuy Synthes Inc Company Overview
  • 5.10 Embody Orthopaedic Ltd Company Overview
  • 5.11 Exactech Inc Company Overview
  • 5.12 FH Ortho Inc Company Overview
  • 5.13 Flexable Orthopedics Company Overview
  • 5.14 Fortis Orthopedics Company Overview
  • 5.15 Fraunhofer Institute for Applied Polymer Research Company Overview
  • 5.16 Hip Innovation Technology LLC Company Overview
  • 5.17 Implants International Ltd Company Overview
  • 5.18 Inor Medical Products Ltd Company Overview
  • 5.19 JRI Orthopaedics Ltd Company Overview
  • 5.20 KYOCERA Medical Corp Company Overview
  • 5.21 Limacorporate SpA Company Overview
  • 5.22 MicroPort Scientific Corp Company Overview
  • 5.23 MX Orthopedics Corp Company Overview
  • 5.24 Nano Interface Technology LLC (Inactive) Company Overview
  • 5.25 OrthoGrid Systems Company Overview
  • 5.26 PreSRV Ltd. Company Overview
  • 5.27 Pro-Dex Inc Company Overview
  • 5.28 Renova Orthopedics LLC (Inactive) Company Overview
  • 5.29 Rochester Institute of Technology Company Overview
  • 5.30 SINTEF Company Overview
  • 5.31 SINTX Technologies Inc Company Overview
  • 5.32 Smith & Nephew Plc Company Overview
  • 5.33 Stanford University Company Overview
  • 5.34 University of Auckland Company Overview
  • 5.35 University of South Florida Company Overview
  • 5.36 University of Southampton Company Overview
  • 5.37 University of Warwick Company Overview
  • 5.38 X-NOV Company Overview
  • 5.39 Zimmer Biomet Holdings Inc Company Overview

6 Hip Reconstruction Devices - Recent Developments

  • 6.1 Aug 30, 2019: BRAIN shares strong nine-month figures demonstrating growth in all areas
  • 6.2 Aug 28, 2019: Medtronic announces planned leadership succession
  • 6.3 Aug 20, 2019: Medtronic reports first quarter financial results for 2019
  • 6.4 Aug 12, 2019: Stryker announces commercial structure realignment
  • 6.5 Aug 07, 2019: Wright Medical Group reports 2019 second quarter financial results
  • 6.6 Aug 06, 2019: Materialise reports second quarter 2019 results
  • 6.7 Aug 05, 2019: Orthofix names Jon Serbousek to Succeed CEO
  • 6.8 Aug 05, 2019: Orthofix reports second quarter 2019 results
  • 6.9 Jul 31, 2019: Smith & Nephew second quarter and first half 2019 results
  • 6.10 Jul 29, 2019: SINTX Technologies provides business update
  • 6.11 Jul 26, 2019: Zimmer Biomet announces second quarter 2019 financial results
  • 6.12 Jul 25, 2019: Stryker reports second quarter 2019 operating results
  • 6.13 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
  • 6.14 Jul 17, 2019: Humana expands reach of value-based orthopedic specialty care to benefit more Humana Medicare Advantage members
  • 6.15 Jul 10, 2019: Implanet reports 2019 first-half revenue of €3.8million
  • 6.16 Jun 19, 2019: Zimmer Biomet announces chief financial officer transition plan
  • 6.17 Jun 14, 2019: Stryker to invest €200m in RD&I projects in Ireland
  • 6.18 May 30, 2019: OrthAlign announces launch of HipAlign application for surgical navigation in total hip arthroplasty
  • 6.19 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
  • 6.20 May 22, 2019: Smith & Nephew's OXINIUM technology for hips could save the US Health System an estimated $296 Million in 2020
  • 6.21 May 20, 2019: Farrer Park Hospital introduces Robotic-Arm Assisted Surgery for full hip and knee replacement procedures
  • 6.22 May 09, 2019: PROTEOR USA announces new President and CEO
  • 6.23 May 07, 2019: Wright Medical Group N.V. Reports 2019 First Quarter Financial Results
  • 6.24 May 07, 2019: Wright Medical Group names Jason Asper as sr. vice president, chief digital officer
  • 6.25 May 07, 2019: Smith & Nephew: Change of registered office
  • 6.26 May 06, 2019: Orthofix reports first quarter 2019 results
  • 6.27 May 02, 2019: Smith & Nephew first quarter 2019 trading report
  • 6.28 Apr 30, 2019: Materialise announces first quarter 2019 results
  • 6.29 Apr 29, 2019: First successful hip replacement surgery completed with Libertas Hip System
  • 6.30 Apr 26, 2019: Zimmer Biomet announces first quarter 2019 financial results

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Table 1: Hip Reconstruction Devices - Pipeline Products by Stage of Development 12
  • Table 2: Hip Reconstruction Devices - Pipeline Products by Segment 13
  • Table 3: Hip Reconstruction Devices - Pipeline Products by Territory 14
  • Table 4: Hip Reconstruction Devices - Pipeline Products by Regulatory Path 15
  • Table 5: Hip Reconstruction Devices - Pipeline Products by Estimated Approval Date 16
  • Table 6: Hip Reconstruction Devices - Ongoing Clinical Trials 17
  • Table 7: Hip Reconstruction Devices Companies - Pipeline Products by Stage of Development 18
  • Table 8: Hip Reconstruction Devices - Pipeline Products by Stage of Development 20
  • Table 9: 4iBIO Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 10: Dynamic Implant - Product Status 22
  • Table 11: Dynamic Implant - Product Description 22
  • Table 12: 4-Web Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 13: Truss Implant - Hip Procedures - Product Status 23
  • Table 14: Truss Implant - Hip Procedures - Product Description 23
  • Table 15: BioPoly RS LLC Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 16: Biopoly RS Partial Resurfacing System - Hip - Product Status 24
  • Table 17: Biopoly RS Partial Resurfacing System - Hip - Product Description 24
  • Table 18: Biotechni SAS Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 19: MULTI-T64 - Product Status 25
  • Table 20: MULTI-T64 - Product Description 25
  • Table 21: MULTI-T66 - Product Status 26
  • Table 22: MULTI-T66 - Product Description 26
  • Table 23: Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 24: JMM Total Hip System - Product Status 27
  • Table 25: JMM Total Hip System - Product Description 27
  • Table 26: Konknow Hip System - Product Status 28
  • Table 27: Konknow Hip System - Product Description 28
  • Table 28: CeramTec GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 29: BIOLOX CONTOURA - Product Status 29
  • Table 30: BIOLOX CONTOURA - Product Description 29
  • Table 31: ConforMIS Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 32: iTotal Hip System - Product Status 30
  • Table 33: iTotal Hip System - Product Description 30
  • Table 34: ConforMIS Inc - Ongoing Clinical Trials Overview 31
  • Table 35: iTotal Hip System - A Prospective, Multicenter Study to Evaluate the Conformis Hip System 32
  • Table 36: Corin Group Plc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 37: Trinity Plus - Product Status 33
  • Table 38: Trinity Plus - Product Description 33
  • Table 39: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 40: Bone Preserving Hip Stem - Product Status 34
  • Table 41: Bone Preserving Hip Stem - Product Description 34
  • Table 42: Hip Resurfacing System - Product Status 35
  • Table 43: Hip Resurfacing System - Product Description 35
  • Table 44: New Poly Hip Bearing - Product Status 35
  • Table 45: New Poly Hip Bearing - Product Description 35
  • Table 46: Next Generation Hip System - Product Status 36
  • Table 47: Next Generation Hip System - Product Description 36
  • Table 48: Embody Orthopaedic Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 49: H1 Hip Resurfacing Implant - Product Status 37
  • Table 50: H1 Hip Resurfacing Implant - Product Description 37
  • Table 51: Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 52: Alteon Acetabular Cup System with XLE Liner - Product Status 38
  • Table 53: Alteon Acetabular Cup System with XLE Liner - Product Description 38
  • Table 54: Alteon Hip Wedge Stem - Product Status 39
  • Table 55: Alteon Hip Wedge Stem - Product Description 39
  • Table 56: Alteon Revision Modular System - Product Status 39
  • Table 57: Alteon Revision Modular System - Product Description 39
  • Table 58: Hip Revision System - Product Status 40
  • Table 59: Hip Revision System - Product Description 40
  • Table 60: FH Ortho Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 61: Press-Fit Dual Mobility Acetabular Cup - Product Status 41
  • Table 62: Press-Fit Dual Mobility Acetabular Cup - Product Description 41
  • Table 63: Tripod Dual Mobility Acetabular Cup - Product Status 42
  • Table 64: Tripod Dual Mobility Acetabular Cup - Product Description 42
  • Table 65: Flexable Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 66: Flex-Able - Product Status 43
  • Table 67: Flex-Able - Product Description 43
  • Table 68: Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 69: MiHip System - Product Status 44
  • Table 70: MiHip System - Product Description 44
  • Table 71: Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 72: Enhanced Durability Resurfacing Endoprosthesis - Product Status 45
  • Table 73: Enhanced Durability Resurfacing Endoprosthesis - Product Description 45
  • Table 74: Hip Innovation Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 75: HIT Hip Replacement System - Product Status 46
  • Table 76: HIT Hip Replacement System - Product Description 46
  • Table 77: Hip Innovation Technology LLC - Ongoing Clinical Trials Overview 47
  • Table 78: HIT Hip Replacement System - A Multi-center Prospective Study of the Hip Innovation Technology (HIT) Hip Replacement System in Primary Total Hip Arthroplasty 48
  • Table 79: Implants International Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 80: Phoenix Re-Surf - Product Status 49

List of Figures

  • Figure 1: Hip Reconstruction Devices - Pipeline Products by Stage of Development 12
  • Figure 2: Hip Reconstruction Devices - Pipeline Products by Segment 13
  • Figure 3: Hip Reconstruction Devices - Pipeline Products by Territory 14
  • Figure 4: Hip Reconstruction Devices - Pipeline Products by Regulatory Path 15
  • Figure 5: Hip Reconstruction Devices - Pipeline Products by Estimated Approval Date 16
  • Figure 6: Hip Reconstruction Devices - Ongoing Clinical Trials 17